Shenzhen Salubris Pharmaceuticals Co. Ltd. (002294)
SZSE
Closed
Sep 18, 2026
Day's Range
30.1252 wk Range
29.25Overview - 002294 - Shenzhen Salubris Pharmaceuticals Co. Ltd.
Key Statistics
Valuation
Enterprise Value
33.14B
P/E (Trailing)
‪51.62‬
P/E (Forward)
‪49.20‬
PEG Ratio
‪49.20‬
Price / Sales (TTM)
‪7.46‬
Price / Book
‪4.08‬
EV / EBITDA
‪31.46‬
Profitability
Gross Margin
‪73.62%‬
Profit Margin
‪14.32%‬
Operating Margin
‪12.65%‬
Return on Assets
‪3.78%‬
Return on Equity
‪7.67%‬
Ownership
Shares Outstanding
1.11B
Float
438.56M
Held by Insiders
‪61.52%‬
Held by Institutions
‪12.90%‬
Price stats
Beta
‪-0.25‬
50-Day Avg
‪34.53‬
200-Day Avg
‪45.60‬
Dividends
Payout Ratio
‪91.67%‬
Frequency
Annual
Analyst Consensus
1 analysts
Market Cap - 002294 - Shenzhen Salubris Pharmaceuticals Co. Ltd.
Peers - 002294 - Shenzhen Salubris Pharmaceuticals Co. Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on SZSE.
- 002294SZSEShenzhen Salubris Pharmaceuticals Co. Ltd.33.52BMarket Cap-76.59%52-week change51.62P/E (Trailing)‪14.32%‬Profit Margin
- 000100SZSETCL Technology Group Corporation101.83BMarket Cap+4.74%52-week change14.97P/E (Trailing)‪3.44%‬Profit Margin
- 000538SZSEYunnan Baiyao Group Co., Ltd.89.92BMarket Cap-17.08%52-week change17.26P/E (Trailing)‪12.48%‬Profit Margin
- 002001SZSEZhejiang NHU Co., Ltd.81.47BMarket Cap+7.02%52-week change11.33P/E (Trailing)‪29.53%‬Profit Margin
- 000963SZSEHuadong Medicine Co., Ltd.46.05BMarket Cap-62.53%52-week change13.26P/E (Trailing)‪7.86%‬Profit Margin
- 000999SZSEChina Resources Sanjiu Medical & Pharmaceutical Co., Ltd.39.75BMarket Cap-22.64%52-week change12.51P/E (Trailing)‪10.30%‬Profit Margin
- 000423SZSEDong-E-E-JiaoCo Ltd.31.06BMarket Cap-4.28%52-week change17.46P/E (Trailing)‪26.23%‬Profit Margin
Profile Summary - 002294 - Shenzhen Salubris Pharmaceuticals Co. Ltd.
About
Shenzhen Salubris Pharmaceuticals Co. Ltd. is a prominent entity in the pharmaceutical industry, primarily engaged in the research, development, production, and sale of a wide range of medicinal products. Its extensive portfolio includes cardiovascular drugs, antibiotics, orthopedics preparations, and central nervous…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
